Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets (Tables)

Intangible Assets (Tables)

9 Months Ended

Aug. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

The impact to future operations is insignificant and it will not impact the Company’s core operations.


	Useful lives		August 31, 2015			November 30, 2014
Patents		10-20 years	$	34,570		$	34,570
License agreement		10 years		430,000			—
Customer relationships		15 years		117,000			—

Less: Accumulated amortization				(16,076	)		(6,212	)


Net Intangible Assets			$	565,494		$	28,358

Schedule of Expected Amortization Expenses

Expected amortization related to these intangible assets for each of the fiscal years ending November 30, 2015 through 2019 and for periods thereafter is as follows:


Period from September 1, 2015 through November 30, 2015	$	13,166
Years ending November 30:
2016		52,663
2017		52,663
2018		52,663
2019		52,663
2020		52,663
Thereafter		289,013

Total	$	565,494